2 news items
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference
ACXP
2 May 24
(SHEA), CDI remains a significant medical problem in hospitals, in long-term care facilities and in the community
Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference
ACXP
25 Apr 24
medical problem in hospitals, in long-term care facilities and in the community. C. difficile is one
- Prev
- 1
- Next